From Groundbreaking to Sky-High Targets: Micron’s New York Megafab Marks a Pivotal Moment for AI Memory

The most ambitious private investment in New York’s history is moving from blueprint to bulldozer. Micron Technology has selected Bechtel to manage the planning and construction of the first phase of its megafab in Clay, a facility designed to become the largest semiconductor plant in the United States. The project sits at the centre of the company’s plan to shift 40% of its global DRAM production to American soil over the next two decades, a response to the insatiable appetite of AI data centres.

The market’s reaction has been unmistakable. Shares surged 6.61% on Thursday to €831.80, pushing the year-to-date advance to 209%. The stock now trades roughly 155% above its 200‑day moving average, a clear technical signal of the bullish sentiment surrounding AI memory chips. Yet the ride remains extreme: annualised volatility stands at 105%, underscoring how sensitive the equity is to every piece of news on capacity and demand.

Analysts are racing to catch up with the narrative. Goldman Sachs raised its price target from $400 to $900, while UBS went further, setting a fair value of $1,625 on the back of Micron’s high‑margin HBM products. The confidence rests on a remarkable supply picture: Micron and its competitors have sold out their entire HBM production capacity through the end of 2026. AI data centres are expected to consume roughly 70% of the world’s memory supply by 2027, turning what was once a long‑term ambition into an urgent operational necessity.

Should investors sell immediately? Or is it worth buying Micron?

The Clay megafab will eventually create 50,000 jobs around the site, with thousands of specialised workers on site during the peak construction phase. Bechtel’s expertise in building precision clean rooms and vibration‑free foundations is critical to ensuring the facility meets the exacting standards of modern chip manufacturing.

All eyes now turn to the next catalyst. On June 24, Micron will report its fiscal third‑quarter results, with analysts projecting a revenue surge to approximately $34.5 billion. Investors will focus on three key areas: details of the HBM4 roadmap, the company’s ability to maintain a gross margin target of 81% amid heavy construction costs, and any new contract wins for 2027 that extend the visibility of the supercycle.

The stock sits just below its early‑June record high, having climbed nearly 220% since the start of the year by some measures. With Bechtel now on board and capacity sold out years in advance, the narrative has shifted from promise to palpable execution. The next earnings print will show whether the stock’s valuation can hold its ground as billions are poured into the ground.